2025 年 10 月 10 日，国际制药巨头百时美施贵宝（BMS）宣布以 15 亿美元的价格现金收购 Orbital Therapeutics。 短短三年时间，体内 CAR-T（in vivo CAR-T）这一领域就实现了从诞生到火爆，融资、合作、巨额收购、临床进展不断。2025 年 6 月，艾伯维宣布以 21 亿美元现金 ...

Cell therapy brings a new dimension to the personalization of cancer care. These treatments are currently made by engineering a patient’s own immune cells into better and more targeted cancer fighters ...

Pharmaceutical marketing has often been viewed through the lens of process and execution – campaigns, timelines, approvals. But at its heart, it’s about connection. It’s about ensuring that the right ...